Trem-2 is a key modulator of mitochondrial respiration, yet its deficiency in AD patients and 5xFAD mouse models of AD enhances autophagy, impairs activation of the mTor pathway, and decreases glycolytic metabolites and tricarboxylic acid (TCA) cycle intermediates [85–87]. The gene discussed is MTOR; the disease is Alzheimer disease.